Tracking Innovation with Thermo Fisher Scientific: CPHI Americas Track Sponsor interview
.png)
As we gear up for CPHI Americas from May 20-22, 2025 at the Philadelphia Convention Center, we sat down with Track Sponsor Thermo Fisher Scientific to discuss the future of bioproduction in pharma.
Kristen Humphrey, Sr. Business Development and Innovative Solutions Specialist at Thermo Fisher Scientific, will be speaking on May 20, 2025 in her session ‘From In-House to Outsourced: Navigating the Buffer Preparation Transition’. Below, she speaks on how Thermo Fisher Scientific aim to showcase the flexibility and scalability of outsourcing buffer and process liquid manufacturing, and what it means for them to sponsor the Bio-innovation track at CPHI Americas.
What do you hope to highlight with the Bio-innovation Track?
We aim to showcase the value of outsourcing buffer and process liquid manufacturing, emphasizing the flexibility and scalability available through the right partner. While outsourcing may initially seem like a significant shift, collaborating with a partner that offers customized, scalable solutions can make the transition seamless and highly beneficial to long-term growth.
What are some key and emerging trends within the R&D space for pharma?
Key emerging trends in pharmaceutical R&D include the development of more targeted and advanced antibody modalities, such as bispecific antibodies and antibody-drug conjugates. Additionally, the continued expansion in the scope and therapeutic potential of cell therapy is driving innovation across the field.
How important will bioproduction and bio-manufacturing be for the future of pharma?
Bioproduction is fundamental to the future of the pharmaceutical industry. The number of biologics under review by the FDA and global regulatory agencies has steadily increased. Coupled with the rapid growth of cell and gene therapy markets, a robust bioproduction infrastructure is essential for supporting innovation and meeting future therapeutic demands.
What does it mean for Thermo Fisher Scientific to be sponsoring this year’s CPHI Americas Bio-innovation track?
It’s an honor to sponsor this year’s R&D and Bio-Manufacturing Track. At Thermo Fisher Scientific, we are committed to advancing scientific discovery through collaboration. Events like CPHI foster critical partnerships that continue to shape the future of biomanufacturing and drive progress across the industry.
What are you most looking forward to this year at CPHI Americas?
We are excited to reconnect with existing collaborators and partners, and equally enthusiastic about building new relationships within the CPHI community. These interactions are vital to fostering innovation and advancing shared goals across the pharmaceutical ecosystem.
Discover the full CPHI Americas agenda here and plan your trip today!
Related News
-
News CPHI Americas 2025 - From the Floor
Our From the Floor live blog is back in Philadelphia for this year’s CPHI, this time under the new name CPHI Americas to embrace and represent the whole of the pharmaceutical supply chain from north to south.
-
News Women in Pharma: Unlocking patient inclusion at CPHI Americas
Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can towards making the healthcare industry and workplace more equitable and inclusive.&nbs... -
News Say hello to the CPHI Exhibitor Spotlight!
We’re kicking off a brand-new series where we shine the spotlight on some of the amazing companies gearing up to shake things up at CPHI Americas 2025 this May! The first company in our spotlight is TAPI, who are set to make a splash at its ve... -
News A Day at CPHI Americas 2025 – What to Expect
CPHI returns to Philadelphia from May 20-22, 2025 under a new name – CPHI Americas. As we aim to bring together pharma professionals for 3 days of innovation and collaboration, CPHI Americas 2025 hopes to recognise the growing influence of the Am...